Kindred Biosciences, Inc.
(NASDAQ : KIN)

( )
KIN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-1.96%146.372.8%$398.46m
MYLMylan N.V.
-1.29%28.323.2%$218.35m
ZTSZoetis, Inc. Class A
0.00%97.931.9%$210.08m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-2.66%15.902.0%$153.38m
TXMDTherapeuticsMD, Inc.
-3.47%5.0125.3%$14.12m
TAROTaro Pharmaceutical Industries Ltd.
-0.95%106.696.4%$7.57m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
2.17%40.012.0%$6.94m
ABEOAbeona Therapeutics, Inc.
-0.13%7.517.8%$3.34m
JAGXJaguar Animal Health, Inc.
-18.83%0.279.8%$2.83m
KINKindred Biosciences, Inc.
2.78%8.500.3%$2.04m
LFVNLifeVantage Corporation
3.60%14.663.3%$1.67m
PETXAratana Therapeutics, Inc.
1.09%3.718.5%$1.31m
CPHIChina Pharma Holdings, Inc.
2.63%0.320.1%$0.31m

Company Profile

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.